• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

狼疮性脑炎对指南指导治疗的抵抗:病例报告。

Lupus Cerebritis Refractory to Guideline-Directed Therapy: A Case Report.

机构信息

SUNY Upstate Medical University, Syracuse, NY, USA.

出版信息

J Investig Med High Impact Case Rep. 2021 Jan-Dec;9:23247096211008708. doi: 10.1177/23247096211008708.

DOI:10.1177/23247096211008708
PMID:33843326
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8042542/
Abstract

Systemic lupus erythematosus is an autoimmune disease that affects multiple organs and organ systems, subsequently requiring an elaborate regimen for management. We present the case of a 63-year-old female who developed unrelenting symptoms of drug-induced lupus, which persisted even after the offending agent was withdrawn, unmasking her underlying systemic lupus erythematosus. She continued to develop neuropsychiatric symptoms, including mania and hallucinations, which complicated the management of her disease. After exhausting the bank of anti-inflammatory and immunomodulators recommended by current guidelines, we found that a combination of rituximab infusions with thiothixene, an antipsychotic agent, significantly improved our patient's neuropsychiatric symptoms. Further research should be conducted to determine the efficacy of rituximab in the treatment of resistant lupus cerebritis, and to validate the use of thiothixene in the management of neuropsychiatric symptoms secondary to lupus.

摘要

系统性红斑狼疮是一种自身免疫性疾病,可影响多个器官和系统,因此需要精心制定治疗方案。我们报告了一例 63 岁女性患者,她出现了药物诱导性狼疮的持续症状,即使停用了致病药物后仍持续存在,从而揭示了她潜在的系统性红斑狼疮。她继续出现神经精神症状,包括躁狂和幻觉,这使她的疾病管理变得复杂。在使用现行指南推荐的所有抗炎和免疫调节剂后,我们发现利妥昔单抗输注联合抗精神病药硫必利显著改善了患者的神经精神症状。应进一步研究以确定利妥昔单抗治疗耐药性狼疮性脑脊髓炎的疗效,并验证硫必利在治疗狼疮继发神经精神症状中的应用。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/db14/8042542/5e619c2f2806/10.1177_23247096211008708-fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/db14/8042542/5e619c2f2806/10.1177_23247096211008708-fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/db14/8042542/5e619c2f2806/10.1177_23247096211008708-fig1.jpg

相似文献

1
Lupus Cerebritis Refractory to Guideline-Directed Therapy: A Case Report.狼疮性脑炎对指南指导治疗的抵抗:病例报告。
J Investig Med High Impact Case Rep. 2021 Jan-Dec;9:23247096211008708. doi: 10.1177/23247096211008708.
2
Systemic Lupus Erythematosus Presenting as Refractory Thrombotic Thrombocytopenic Purpura: A Diagnostic and Management Challenge. A Case Report and Concise Review of the Literature.以难治性血栓性血小板减少性紫癜为表现的系统性红斑狼疮:诊断与管理挑战。病例报告及文献简要综述
Am J Case Rep. 2016 Oct 25;17:782-787. doi: 10.12659/ajcr.898955.
3
Efficacy and safety of anti-CD20 antibody rituximab for patients with refractory systemic lupus erythematosus.抗CD20抗体利妥昔单抗治疗难治性系统性红斑狼疮患者的疗效和安全性。
Lupus. 2018 Apr;27(5):802-811. doi: 10.1177/0961203317749047. Epub 2018 Jan 7.
4
Successful treatment of refractory acute lupus haemophagocytic syndrome using rituximab: a case report.利妥昔单抗成功治疗难治性急性狼疮噬血细胞综合征:一例报告。
Mod Rheumatol Case Rep. 2020 Jul;4(2):222-228. doi: 10.1080/24725625.2019.1705529. Epub 2020 Jan 6.
5
Toxoplasma infection in systemic lupus erythematosus mimicking lupus cerebritis.系统性红斑狼疮中弓形虫感染酷似狼疮性脑病。
Mayo Clin Proc. 1999 Jun;74(6):575-8. doi: 10.4065/74.6.575.
6
Myelitis and Lupus: Clinical Manifestations, Diagnosis and Treatment. Review.脊髓炎与狼疮:临床表现、诊断与治疗。综述。
Reumatol Clin. 2017 Nov-Dec;13(6):344-348. doi: 10.1016/j.reuma.2016.06.004. Epub 2016 Aug 24.
7
Current role of rituximab in systemic lupus erythematosus.利妥昔单抗在系统性红斑狼疮中的当前作用。
Int J Rheum Dis. 2015 Feb;18(2):154-63. doi: 10.1111/1756-185X.12463. Epub 2014 Dec 19.
8
Successful long-term treatment of systemic lupus erythematosus with rituximab maintenance therapy.利妥昔单抗维持疗法对系统性红斑狼疮的长期成功治疗。
Lupus. 2003;12(10):779-82. doi: 10.1191/0961203303lu449cr.
9
Diversity of neuropsychiatric manifestations in systemic lupus erythematosus.系统性红斑狼疮神经精神症状的多样性
Immunol Med. 2020 Dec;43(4):135-141. doi: 10.1080/25785826.2020.1770947. Epub 2020 May 27.
10
Novel use of rituximab in macrophage activation syndrome secondary to systemic lupus erythematosus.利妥昔单抗在系统性红斑狼疮继发巨噬细胞活化综合征中的新用途。
BMJ Case Rep. 2017 Aug 21;2017:bcr-2017-221347. doi: 10.1136/bcr-2017-221347.

本文引用的文献

1
Drug-induced lupus erythematosus: an update on drugs and mechanisms.药物诱导性红斑狼疮:药物和机制的最新研究进展。
Curr Opin Rheumatol. 2018 Sep;30(5):490-497. doi: 10.1097/BOR.0000000000000522.
2
Thiothixene in the Management of Delirium: A Case Series.硫利达嗪治疗谵妄:病例系列
Psychosomatics. 2015 Sep-Oct;56(5):542-6. doi: 10.1016/j.psym.2015.02.003. Epub 2015 Feb 16.
3
Efficacy and safety of rituximab in moderately-to-severely active systemic lupus erythematosus: the randomized, double-blind, phase II/III systemic lupus erythematosus evaluation of rituximab trial.
利妥昔单抗治疗中度至重度活动性系统性红斑狼疮的疗效和安全性:利妥昔单抗治疗系统性红斑狼疮的随机、双盲、II/III期试验
Arthritis Rheum. 2010 Jan;62(1):222-33. doi: 10.1002/art.27233.
4
Drug-induced lupus erythematosus.药物性红斑狼疮
Arch Dermatol Res. 2009 Jan;301(1):99-105. doi: 10.1007/s00403-008-0895-5. Epub 2008 Sep 17.
5
Drug-induced lupus.药物性狼疮。
Ann N Y Acad Sci. 2007 Jun;1108:166-82. doi: 10.1196/annals.1422.019.
6
[Neuropsychiatric involvement in systemic lupus erythematosus. Part 2: diagnostic and therapy].[系统性红斑狼疮的神经精神受累。第2部分:诊断与治疗]
Med Klin (Munich). 2003 Feb 15;98(2):79-90. doi: 10.1007/s00063-003-1230-8.
7
Minocycline-induced lupus. A systematic review.米诺环素诱发的狼疮。一项系统评价。
Dermatology. 2000;200(3):223-31. doi: 10.1159/000018387.
8
New concepts in the pathogenesis of drug-induced lupus.药物性狼疮发病机制的新概念。
Lab Invest. 1995 Dec;73(6):746-59.
9
Neuropsychiatric lupus erythematosus: a 10-year prospective study on the value of diagnostic tests.神经精神性红斑狼疮:一项关于诊断试验价值的10年前瞻性研究。
Am J Med. 1995 Aug;99(2):153-63. doi: 10.1016/s0002-9343(99)80135-1.